Yan Zhao

Dr. Yan Zhao

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2018 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
LLLin Li
Lin Li
WZWenzhuo Zhao
Wenzhuo Zhao
MWMengmeng Wang
Mengmeng Wang
JHJie Hu
Jie Hu
EWEnxin Wang
Enxin Wang
LLLei Liu
Lei Liu
Transarterial chemoembolization (TACE) is the recommended treatment for hepatocellular carcinoma (HCC) patients at Barcelona Clinic Liver Cancer (BCLC) B-stage, whereas sorafenib is an orally administered small molecule target drug for BCLC C-stage. This updated systemic review and meta-analysis focuses on identifying the efficacy of the combination of TACE with sorafenib, which remains controversial despite years of exploration. PubMed, EMBASE, Scopus and the Cochrane Library were systematically reviewed to search for studies published from January 1990 to May 2017. Studies focusing on the efficacy of combination therapy for unresectable HCC were eligible. The hazard ratio (HR) with 95% confidence intervals (95% CIs) for time to progression (TTP), overall survival (OS), disease control rate (DCR) and aetiology were collected. The data were then analysed through fixed/random effects meta-analysis models with STATA 13.0. The incidence and severity of treatment-related adverse events (AEs) were also evaluated. Twenty-seven studies were included. Thirteen non-comparative studies reported median OS (ranging from 18.5 to 20.4 months), median TTP (ranging from 7 to 13.9 months) and DCR (ranging from 18.4 to 95%). Fourteen comparative studies provided median OS (ranging from 7.0 to 29.7 months) and median TTP (ranging from 2.6 to 10.2 months). Five comparative studies provided DCR (ranging from 32 to 97.2%). Forest plots showed that combination therapy significantly improved TTP (HR = 0.66, 95% CI 0.50–0.81, P = 0.002) rather than OS (HR = 0.63, 95% CI 0.55–0.71, P = 0.058), compared to TACE alone. DCR increased significantly in the combination therapy group (OR = 2.93, 95% CI 1.59–5.41, P = 0.005). Additional forest plots were drawn and no significant differences were observed with regard to survival outcome among various aetiologies. Forest plots for separate analysis of regions showed the HR for TTP was 0.62 (95% CI 0.45–0.79, P = 0.002) in the Asian countries group, and 0.82 (95% CI 0.59–1.05, P = 0.504)) in western countries. The HR for OS was 0.61 (95% CI 0.48–0.75, P = 0.050) in the Asian countries group and was 0.88 (95% CI 0.56–1.20, P = 0.845) in western countries. These data may indicate positive TTP outcome in Asian patients but not in European patients while no positive findings regarding OS were observed in either region. The most common AEs included fatigue, hand-foot skin reaction, diarrhoea and hypertension. Combination therapy may benefit unresectable HCC patients in terms of prolonged TTP and DCR. More well-designed studies are needed to investigate its superiority for OS.

23 May 2015 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
ZWZhijun Wang
Zhijun Wang
RCRongxin Chen
Rongxin Chen
RDRafael Duran
Rafael Duran
YZYan Zhao
Yan Zhao
GYGayane Yenokyan
Gayane Yenokyan
JGJean-François Geschwind
Jean-François Geschwind

7 August 2022 in Neurobiology of Stress
Verified
Journal Article
Open access
GCGuo-hong Cai
Guo-hong Cai
YLYifan Lu
Yifan Lu
JCJing Chen
Jing Chen
DYDingding Yang
Dingding Yang
RYRuixuan Yan
Ruixuan Yan
YZYan Zhao
Yan Zhao
Chronic sleep deprivation (SD) is a common problem for humans and can lead to many deleterious effects, including depression, anxiety, stroke, permanent cognitive deficits, stress, and other physiological diseases. It is vital to acquire information about the relevant neural activities at the whole-brain level to systematically explore the mechanisms of brain dysfunction related to SD. Expression of the immediate-early gene (IEG) Fos in the mouse brain has been widely used as a functional marker of brain activity in the field of neuroscience. However, most previous studies only analyzed the change of c-Fos in several specific brain regions using traditional research methods or in short-term SD model. Here, we applied c-Fos mapping through the fluorescence micro-optical sectioning tomography (fMOST) technique and AAV-PHP.eB to comprehensive analysis the state of cumulative activation across the whole brain in a mouse model of chronic SD. The chronic rapid eyes movement (REM) SD model was induced by moving mice to a separate holding area filled with water. The experimental period lasted for 6 h per day. The results showed that after 14 days of SD, the mice displayed anxiety-like behaviors in open field test and elevated plus maze test, and displayed depression-like behaviors in tail suspension test and the sucrose preference test. The c-Fos + cells were detected in a maximum of 230 brain regions. SD-induced stress model evoked c-Fos expression in several brain regions compared to the control group. In particular, the isocortex-cerebral cortex plate area, including the retrosplenial, anterior cingulate, agranular insular, gustatory, and parasubiculum, appear to be the most sensitive regions after chronic REM SD.

30 October 2017 in CardioVascular and Interventional Radiology
Verified
Journal Article
Open access
PDF file
YZYan Zhao
Yan Zhao
RDRafael DURAN
Rafael DURAN
WBWei Bai
Wei Bai
SSSonia Sahu
Sonia Sahu
WWWenjun Wang
Wenjun Wang
JGJean-François Geschwind
Jean-François Geschwind
Purpose Our study aimed to evaluate quantitative tumor response assessment (quantitative EASL-[qEASL]) on computed tomography (CT) images in patients with hepatocellular carcinoma (HCC) treated using conventional transarterial chemoembolization (cTACE), compared to existing 1-dimensional and 2-dimensional methods (RECIST, mRECIST, EASL). Materials and Methods In this IRB-approved, single-institution retrospective cohort study, 52 consecutive patients with intermediate-stage HCC were consecutively included. All patients underwent contrast-enhanced CT scan at baseline and 4 weeks after cTACE. Results Median follow-up period was 13.5 months (range 1.2–54.1). RECIST, mRECIST and EASL identified progression in 2 (4%), 1 (2%) and 1 (2%) patients, respectively, whereas qEASL identified 10 (19%) patients. qEASL was the only tumor response method able to predict survival among different tumor response groups (P < 0.05), whereas RECIST, mRECIST and EASL did not (P > 0.05). Both EASL and qEASL were able to identify responders and non-responders and were predictive of survival (P < 0.05). Multivariate analysis showed that progression was an independent predictor of overall survival with hazard ratio of 1.9 (P = 0.025). Patients who demonstrated progression with qEASL had significantly shorter survival than those with non-progression (7.6 vs. 20.4 months, P = 0.012). Similar multivariate analysis using RECIST, mRECIST and EASL could not be performed because too few patients were categorized as progressive disease. Conclusion qEASL could be applied on CT images to assess tumor response following cTACE and is a more sensitive biomarker to predict survival and identify tumor progression than RECIST, mRECIST and EASL at an early time point. Level of Evidence Level 2a, retrospective cohort study.

5 July 2016 in CardioVascular and Interventional Radiology
Verified
Journal Article
Open access
PDF file
RSRuediger E. Schernthaner
Ruediger E. Schernthaner
RHReham R. Haroun
Reham R. Haroun
RDRafael Duran
Rafael Duran
HLHoward Lee
Howard Lee
SSSonia Sahu
Sonia Sahu
JGJean Francois Geschwind
Jean Francois Geschwind
To compare the visibility of liver metastases on dual-phase cone-beam CT (DP-CBCT) and digital subtraction angiography (DSA), with reference to preinterventional contrast-enhanced magnetic resonance imaging (CE-MRI) of the liver.

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
YZYan Zhao
Yan Zhao
MRMudan Ren
Mudan Ren
GLGuifang Lu
Guifang Lu
XLXinlan Lu
Xinlan Lu
YYYan Yin
Yan Yin
SHShuixiang He
Shuixiang He
Background. Acute variceal bleeding is a major cause of death in liver cirrhosis. This large scale retrospective cohort study aims to analyze the prognosis of patients with cirrhosis and acute variceal bleeding and to validate the current prognostic models. Methods. Patients with cirrhosis and acute variceal bleeding were enrolled from Jan 2019 to March 2020. The independent prognostic factors for in‐hospital death were identified by logistic regression analyses. Area under curves (AUCs) was compared among Child‐Pugh, cirrhosis acute gastrointestinal bleeding (CAGIB) score, and model for end‐stage liver disease (MELD) and neutrophil‐lymphocyte ratio (NLR) scores. Results. Overall, 379 patients with liver cirrhosis and acute variceal bleeding were consecutively evaluated. The majority of the patients were males (59.1%) and the mean age of all patients were 53.7 ± 1.3 years (range 14‐89). Hepatitis B virus (HBV) was the most common underlying cause of liver cirrhosis (54.1%). 72 (19%) patients had hepatocellular carcinoma. Multivariate logistic regression analyses showed that age, HCC, WBC, total serum bilirubin, serum creatinine, and ALT were independently associated with in‐hospital death. And the odds ratios (ORs) for in‐hospital death were 1.066 (95% CI 1.017‐1.118, P = 0.008), 7.19 (95% CI 2.077‐24.893, P = 0.001), 1.123 (95% CI 1.051‐1.201, P = 0.001), 1.014 (95% CI 1.005‐1.023, P = 0.003), 1.012 (95% CI 1.004‐1.021, P = 0.006), and 1.005 (95% CI 1.000‐1.009, P = 0.036), respectively. In the whole cohort with HCC patients, the AUCs of Child‐Pugh, CAGIB, MELD and NLR scores were 0.842 (95% CI 0.801‐0.878), 0.840 (95% CI 0.799‐0.876), 0.798 (95% CI 0.754‐0.838), and 0.688 (95% CI 0.639‐0.735), respectively. The differences were statistically significant between Child‐Pugh and NLR scores (P = 0.0118), and between CAGIB and NLR scores (P = 0.0354). Conclusion. Child‐Pugh and CAGIB scores showed better predictive performance for prognosis of patients with cirrhosis and acute variceal bleeding than NLR scores.